Christopher Troianos, MD
- Call 216.444.0447
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Christopher Troianos, MD
Christopher A. Troianos, MD, FASE is Chair of the Anesthesiology Institute of the Cleveland Clinic, which unites all anesthesiology providers in general anesthesiology, cardiothoracic anesthesiology, pain medicine, pediatric & congenital cardiac anesthesiology, critical care medicine, regional practice, outcomes research, education, and more than 15 subspecialized sections within one fully integrated model of care.
Dr. Troianos received a Bachelor of Science degree with University Honors in Chemistry from Carnegie Mellon University and his medical degree from the University of Pittsburgh School of Medicine. He completed a residency in anesthesiology, followed by a cardiothoracic anesthesiology fellowship at the Hospital of the University of Pennsylvania. He is board-certified in anesthesiology, a senior oral board examiner with the American Board of Anesthesiology, and a fellow of the American Society of Echocardiography.
Dr. Troianos has earned a national and international reputation as a cardiac anesthesiologist and participated on several national task forces that required collaboration among multispecialty societies to develop practice guidelines. He was part of the original task force that developed training guidelines in perioperative TEE and subsequently quality improvement guidelines in perioperative TEE. Most recently, he was the lead author for practice guidelines for ultrasound guided vascular access. He has shared his expertise in numerous peer-reviewed publications, authored the anesthesiology textbook, “Anesthesia for the Cardiac Patient.”, and has been an invited speaker to national and international scientific educational conferences. His experience with graduate medical education spans two decades, having served as a Residency Program at two institutions, and as Chair of the Graduate Medical Education Committee at Mercy Hospital in Pittsburgh.
Dr. Troianos is currently serving as President-Elect of the Society of Cardiovascular Anesthesiologists (SCA), and will become President of the SCA in 2017. He also serves on the Board of Directors for the National Board of Echocardiography, which develops certification examinations and recognizes physicians who fulfill the requirements for board certification in echocardiography. Dr. Troianos has served as the Chair of the Society of Cardiovascular Anesthesiologists (SCA) Economics Committee and as the cardiac anesthesia liaison for the American Society of Anesthesiologists (ASA) Committee on Economics. This committee focuses on ensuring fair payment from all payers for anesthesiology services, and is one of the most important committees of the ASA on a national level.
Education & Professional Highlights
Appointed
2016
Education & Fellowships
Fellowship - Hospital of the University of Pennsylvania
Cardiothoracic Anesthesiology
Philadelphia,
PA USA
1991
Residency - UPMC Mercy Hospital of Pittsburgh
Anesthesiology
Pittsburgh,
PA USA
1989
Medical Education - University of Pittsburgh School of Medicine
Pittsburgh,
PA USA
1985
Undergraduate - Carnegie Mellon University
Chemistry
Pittsburgh,
PA USA
1981
Certifications
- Anesthesiology
Research & Publications
See publications for Christopher Troianos, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 12/29/2022, Dr. Troianos has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Fiduciary Role. Dr. Troianos serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:
- National Board of Echocardiography, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
